2016
DOI: 10.1055/s-0042-102652
|View full text |Cite|
|
Sign up to set email alerts
|

Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines

Abstract: ACS Acute coronary syndrome ADP Adenosine diphosphate AF Atrial fibrillation APA Antiplatelet agents APTT Activated partial thromboplastin time This article is published simultaneously in the journals Endoscopy and Gut.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
216
0
3

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 197 publications
(223 citation statements)
references
References 109 publications
4
216
0
3
Order By: Relevance
“…For patients taking warfarin or antiplatelet treatment, the previous BSG guideline95 has been incorporated into a new BSG and ESGE guideline,96 which includes advice on patients prescribed DOACs. This class of drugs include factor 10a inhibitors (rivaroxaban, apixiban) and the thrombin inhibitor dabigatran.…”
Section: Endoscopic Management Of Cbdsmentioning
confidence: 99%
“…For patients taking warfarin or antiplatelet treatment, the previous BSG guideline95 has been incorporated into a new BSG and ESGE guideline,96 which includes advice on patients prescribed DOACs. This class of drugs include factor 10a inhibitors (rivaroxaban, apixiban) and the thrombin inhibitor dabigatran.…”
Section: Endoscopic Management Of Cbdsmentioning
confidence: 99%
“…Patients must have provided adequate consent and should be warned of procedure risks such as bleeding, which can be delayed for up to 3 weeks postprocedure, and of the need for surgery should an intraperitoneal perfor ation occur that cannot be managed with endoscopic clips. Patients should stop taking anticoagulants before EMR or ESD, with appropriate heparin cover for those at increased risk of thromboembolism [29][30][31] . Little evi dence exists that lowdose aspirin (75 mg) adversely affects bleeding risk, and continuing to take this drug might be important to reduce the risk of cardiac events in those with marked cardiovascular disease 32 .…”
Section: Preparation For Emr or Esdmentioning
confidence: 99%
“…Little evi dence exists that lowdose aspirin (75 mg) adversely affects bleeding risk, and continuing to take this drug might be important to reduce the risk of cardiac events in those with marked cardiovascular disease 32 . However, clopidogrel and other potent antiplatelet agents should be stopped for at least 5 days before either procedure 31 . Most EMR resections can be performed under conscious sedation, although procedures that are anticipated to take a long time (ESD, very large PEMR) or resections close to the dentate line might be more comfortably per formed with propofol deep sedation or general anaesthe sia.…”
Section: Preparation For Emr or Esdmentioning
confidence: 99%
“…При рассмотрении проблемы возобновления АТТ после кровопотери следует выделить вопросы терапии при кровотечении из ЖКТ и кровотечении у больных ИБС, имеющих фибрилляцию предсердий, на фоне приема антикоагулянтов [16]. Желудочно-кишечные кровотече-ния (ЖКК) -частое осложнение, наблюдаемое у больных ИБС, получающих АТТ, поскольку один из основных анти-агрегантов -АСК обладает проульцерогенным эффектом.…”
unclassified
“…Угроза возникновения кровопотерь возникает при выполнении некоторых дополнительных манипуляций: полипэктомии, дилатации стриктур и про-цедуры стентирования ЖКТ, лечении варикоза пищевода, при эндоскопических хирургических вмешательствах, в случае диссекции слизистой [16]. Добавление в терапию ингибиторов протонных помп рекомендуется во всех случаях состоявшихся кровотечений из верхних отделов ЖКТ, а также профилактически при их высоком риске.…”
unclassified